Zeit | Aktuelle Nachrichten | Rating | Leser | ||
---|---|---|---|---|---|
Do | KEFI Gold and Copper - Code word imminent | 233 | Since our last note at the end of March, KEFI has appointed BCM as its preferred mining contractor and raised £7.6m in equity (supported by Konwave, Phoenix, Premier Miton, RAB and Ruffer, among others)... ► Artikel lesen | ||
Do | Cereno Scientific - Phase II calling for CS014 after Phase I success | 174 | Cereno Scientific reported positive Phase I readouts for CS014, its novel HDAC inhibitor, paving the way for Phase II studies in idiopathic pulmonary fibrosis (IPF). The candidate demonstrated favourable... ► Artikel lesen | ||
Di | Baker Steel Resources Trust - High interest in assets, 16.4% return in H125 | 208 | Baker Steel Resources Trust (BSRT) reported a strong monthly NAV uplift of 13.2% in June 2025 (bringing the H125 NAV total return to 16.4%) following its latest interim valuations update, with multiple... ► Artikel lesen | ||
Di | International Public Partnerships - Operational and financial performance on track | 195 | International Public Partnerships' (INPP's) recent portfolio update showed its portfolio is continuing to perform well, with further progress on accretive capital recycling. INPP shares offer an attractive... ► Artikel lesen | ||
Di | Zinc Media - Newly defined growth pillars and targets | 218 | Zinc Media continues to win significant new commissions from a wide range of channels and streamers and to build its profile in the market. FY25 market estimates are underpinned by revenues secured... ► Artikel lesen | ||
Mo | Filtronic - £13.4m contract with defence prime | 186 | Filtronic has signed a contract with a defence prime worth £13.4m, with expected delivery from mid-CY26. This contract helps diversify the company's revenue base and highlights progress in the aerospace... ► Artikel lesen | ||
11.07. | Greggs - Sales growth slows as the country bakes | 251 | Greggs' H125 trading update showed sales growth slowed in June as high temperatures affected footfall and purchasing patterns. Although the company benefits from sales of cold drinks, including its... ► Artikel lesen | ||
11.07. | The Pebble Group - On track, with further tender offer | 197 | Pebble Group's H125 update indicates trading is on track to meet FY25 market expectations, despite a difficult macroeconomic backdrop and currency headwinds. We have made small forecast revisions to... ► Artikel lesen | ||
11.07. | Oncodesign Precision Medicine - Precision therapies for resistant diseases | 220 | Oncodesign Precision Medicine (OPM) is a clinical-stage biopharmaceutical company listed on Euronext Growth Paris. OPM is developing precision medicine therapies targeting treatment-resistant and metastatic... ► Artikel lesen | ||
11.07. | Oryzon Genomics - KOL event highlights vafidemstat potential in BPD | 222 | At Oryzon Genomics' key opinion leader (KOL) event, vafidemstat's path through Phase III in borderline personality disorder (BPD) was laid out. The significant unmet need was highlighted, as there are... ► Artikel lesen | ||
09.07. | Henderson Far East Income - Positioned to benefit as Asia outperforms | 249 | Asian equities have outperformed the US and global markets this year and the manager of Henderson Far East Income (HFEL), Sat Duhra, expects this outperformance to continue, underpinned by a number... ► Artikel lesen | ||
09.07. | Solid State - FY26 started positively | 218 | Solid State's FY25 was affected by contract timings. However, FY26 has started positively with a strong order book (+13.9% y-o-y). This suggests the company is back on track, offering a return to the... ► Artikel lesen | ||
08.07. | VEON - Catalysts from Kyivstar IPO and buyback | 920 | VEON's financial performance at the Q125 stage was strong, and importantly the Ukrainian business that is to be listed in the coming months was solid. Investor attention is now on the Kyivstar IPO,... ► Artikel lesen | ||
08.07. | bp - Focusing on returns and growth | 380 | bp is pivoting back towards its traditional upstream oil and gas business, with a renewed focus on shareholder returns. It will remain an integrated energy play with strong differentiating factors (trading... ► Artikel lesen | ||
07.07. | IntelliAM AI - US initiative accompanies FY25 accounts | 202 | The publication of IntelliAM AI's FY25 accounts (results were released in May) shortly followed the news of a strategic partnership with US sensor provider CTC. While the full accounts and the positive... ► Artikel lesen | ||
07.07. | PWO Group - Automotive play in lightweight components | 316 | PWO Group specialises in lightweight metal components for the automotive industry, with the focus on mass production of tailor-made solutions that often have volumes of several million units per series.... ► Artikel lesen | ||
07.07. | Actinogen Medical - XanaMIA study enrols 100th patient | 275 | Actinogen Medical announced on 30 June that it has recruited the 100th patient for its ongoing XanaMIA Phase IIb/III study assessing lead candidate Xanamem (emestedastat) in patients with biomarker-positive... ► Artikel lesen | ||
04.07. | Patria Private Equity Trust - Market slowdown limited returns in H125 | 256 | Patria Private Equity Trust (PPET) reported a moderate 2.6% NAV total return in H125, as its near-term return potential remains constrained by subdued private equity (PE) market activity. PE transaction... ► Artikel lesen | ||
03.07. | JPMorgan European Discovery Trust - Set to benefit from Europe's reawakening | 250 | JPMorgan European Discovery Trust (JEDT) invests in European small-cap companies (excluding UK). Its objective is to identify and invest early in smaller companies demonstrating improving operational... ► Artikel lesen | ||
03.07. | AFT Pharmaceuticals - Making progress on growth strategy | 270 | AFT Pharmaceuticals has provided an investor update for Q2 CY25 (Q1 FY26), summarising material progress made across its global expansion and R&D-driven growth strategy. The highlight of the period... ► Artikel lesen | ||
02.07. | Zalaris - Positive contract progress in Q2 | 258 | Zalaris has recently signed a contract extension with a Nordic financial institution; the value of the extension makes up a significant proportion of the nearly NOK35m of annual contract value (ACV)... ► Artikel lesen | ||
02.07. | Newron Pharmaceuticals - Evenamide enters ENIGMA-TRS programme | 298 | Newron Pharmaceuticals is making significant headway in progressing its drug candidate, evenamide, to become an effective treatment option for patients suffering with treatment-resistant schizophrenia... ► Artikel lesen | ||
02.07. | Singapore Post - Searching for a new CEO | 310 | Singapore Post (SingPost) has experienced significant changes over the last six months, and further change is likely as the company searches for a new CEO. We expect a strategy update following the... ► Artikel lesen | ||
02.07. | VolitionRx - Nu.Q advances in lung cancer management | 313 | Despite rapid advancements in cancer treatments, effective diagnostics for early screening and disease monitoring continue to be an unmet need. This is felt acutely in lung cancer, which is the leading... ► Artikel lesen | ||
01.07. | Record PLC - Building foundations for growth | 262 | Record's FY25 results (to 31 March) were robust, with assets under management equivalent (AUME) remaining above $100bn. Progress with the company's strategic refocus on core products that can grow,... ► Artikel lesen |